HemCon Medical Technologies and Zimmer Dental sign distribution agreement

NewsGuard 100/100 Score

HemCon Medical Technologies, Inc. (“HemCon”), a leading developer of advanced medical products, is proud to announce the signing of an exclusive global distribution agreement with Zimmer Dental Inc., a leading provider of dental oral rehabilitation products and a subsidiary of Zimmer Holdings, Inc. Through this agreement, Zimmer Dental will supply HemCon’s line of revolutionary oral wound care dressings for all dental applications throughout the globe.

HemCon Dental Dressings are based on HemCon’s unique chitosan platform technology which is most notably being used as the basis for their proprietary hemorrhage control bandages on the battlefield and in acute care settings. HemCon Dental Dressings effectively seal any oral wound and minimize pain in various dental, periodontal, and oral surgery procedures, culminating in a more positive experience for both clinicians and patients.

“HemCon is excited to aggressively pursue these markets with a strong partner like Zimmer Dental whose hundreds of global sales representatives will assist in penetrating key markets around the world,” said HemCon CEO John W. Morgan. “Along with our hemostatic HemCon® dressings, our HemCon Dental Dressings will broaden the positive impact our technological innovations offer to improve care for patients on a global scale.”

For decades, Zimmer Dental has gained the trust of thousands of clinicians worldwide who count on its comprehensive line of scientifically-proven products to deliver successful patient outcomes and the best value in the industry. “We have been looking for a new innovative product to broaden the scope of our industry-leading family of regenerative products,” said Harold C. Flynn, Jr., Zimmer Dental’s President. “We feel that the HemCon Dental Dressing reinforces Zimmer Dental’s ongoing goal of empowering clinicians and shaping the future of implant dentistry.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Horse sedative use among humans spreads in deadly mixture of ‘tranq’ and fentanyl